诚达药业：股票交易异常波动

Core Viewpoint - The stock of Chengda Pharmaceutical experienced an abnormal trading fluctuation, with a cumulative price increase of over 30% over two consecutive trading days, prompting an inquiry by the Shenzhen Stock Exchange [1] Summary by Relevant Sections - Stock Price Movement - Chengda Pharmaceutical's stock price increased by over 30% from November 13 to November 14, 2025, indicating significant trading volatility [1] - Company Confirmation - The company's board confirmed that there are no corrections or supplements needed for previously disclosed information, and there are no undisclosed significant matters that could impact the stock price [1] - Market Environment - The company stated that its operational situation remains normal, with no significant changes in the internal or external environment [1] - Insider Trading - The controlling shareholders and actual controllers did not engage in buying or selling the company's stock during the period of abnormal price fluctuation [1] - Disclosure Compliance - The company affirmed that it has not violated any fair information disclosure regulations and that there are no undisclosed matters that could significantly affect the stock price [1]